Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Bukreyev

Showing results (131-140 of 169) with videos related to

Pageof 17
Sort By:
Science (New York, N.Y.)|April 30, 2016
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammationAlex Rialdi, Laura Campisi, Nan Zhao, et al.
JCI Insight|January 11, 2021
Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022Caroline Atyeo, Matthew D Slein, Stephanie Fischinger, et al.
Cell|January 26, 2016
Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus InfectionAndrew I Flyak, Xiaoli Shen, Charles D Murin, et al.
Frontiers in Immunology|April 28, 2022
Asymptomatic SARS-CoV-2 Infection Is Associated With Higher Levels of Serum IL-17C, Matrix Metalloproteinase 10 and Fibroblast Growth Factors Than Mild Symptomatic COVID-19Alessandra Soares-Schanoski, Natalie Sauerwald, Carl W Goforth, et al.
Nature Communications|October 3, 2022
IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concernMatthew R Chang, Luke Tomasovic, Natalia A Kuzmina, et al.
Elife|March 27, 2023
Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodiesTaylor B Engdahl, Elad Binshtein, Rebecca L Brocato, et al.
Cell Reports|April 8, 2023
Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypesElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Immunity|April 14, 2021
A Fc engineering approach to define functional humoral correlates of immunity against Ebola virusBronwyn M Gunn, Richard Lu, Matthew D Slein, et al.
Cell Reports|September 30, 2021
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognitionKevin J Kramer, Nicole V Johnson, Andrea R Shiakolas, et al.
Microbiology Spectrum|November 14, 2022
Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic InfectionSindhu Vangeti, Sivakumar Periasamy, Peifang Sun, et al.
Pageof 17

Showing results (131-140 of 169) with videos related to

Sort By:
Pageof 17
Science (New York, N.Y.)|April 30, 2016
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammationAlex Rialdi, Laura Campisi, Nan Zhao, et al.
JCI Insight|January 11, 2021
Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022Caroline Atyeo, Matthew D Slein, Stephanie Fischinger, et al.
Cell|January 26, 2016
Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus InfectionAndrew I Flyak, Xiaoli Shen, Charles D Murin, et al.
Frontiers in Immunology|April 28, 2022
Asymptomatic SARS-CoV-2 Infection Is Associated With Higher Levels of Serum IL-17C, Matrix Metalloproteinase 10 and Fibroblast Growth Factors Than Mild Symptomatic COVID-19Alessandra Soares-Schanoski, Natalie Sauerwald, Carl W Goforth, et al.
Nature Communications|October 3, 2022
IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concernMatthew R Chang, Luke Tomasovic, Natalia A Kuzmina, et al.
Elife|March 27, 2023
Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodiesTaylor B Engdahl, Elad Binshtein, Rebecca L Brocato, et al.
Cell Reports|April 8, 2023
Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypesElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Immunity|April 14, 2021
A Fc engineering approach to define functional humoral correlates of immunity against Ebola virusBronwyn M Gunn, Richard Lu, Matthew D Slein, et al.
Cell Reports|September 30, 2021
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognitionKevin J Kramer, Nicole V Johnson, Andrea R Shiakolas, et al.
Microbiology Spectrum|November 14, 2022
Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic InfectionSindhu Vangeti, Sivakumar Periasamy, Peifang Sun, et al.
Pageof 17